Detalhe da pesquisa
1.
The evolution of lung cancer and impact of subclonal selection in TRACERx.
Nature
; 616(7957): 525-533, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37046096
2.
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study.
Lancet
; 402(10400): 451-463, 2023 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37423228
3.
Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.
Nature
; 554(7691): 264, 2018 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29258292
4.
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.
Nature
; 545(7655): 446-451, 2017 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-28445469
5.
Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study.
Lancet Oncol
; 23(6): 748-757, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35617989
6.
Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.
N Engl J Med
; 378(2): 113-125, 2018 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29151359
7.
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study.
Lancet Oncol
; 21(10): 1309-1316, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32853557
8.
Tracking the Evolution of Non-Small-Cell Lung Cancer.
N Engl J Med
; 376(22): 2109-2121, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28445112
9.
Tracking genomic cancer evolution for precision medicine: the lung TRACERx study.
PLoS Biol
; 12(7): e1001906, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25003521
10.
First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 13(11): 1161-70, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23078958
11.
Optimising fusion detection through sequential DNA and RNA molecular profiling of non-small cell lung cancer.
Lung Cancer
; 161: 55-59, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34536732
12.
Anti-angiogenesis drugs in lung cancer.
Respirology
; 15(3): 387-92, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20337999
13.
Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trial.
Lancet Respir Med
; 8(9): 895-904, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32199466
14.
The clinical role of VeriStrat testing in patients with advanced non-small cell lung cancer considered unfit for first-line platinum-based chemotherapy.
Eur J Cancer
; 120: 86-96, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31499384
15.
Phase II trial of thalidomide with chemotherapy and as maintenance therapy for patients with poor prognosis small-cell lung cancer.
Lung Cancer
; 59(3): 364-8, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17920723
16.
A phase I study of nintedanib combined with cisplatin/gemcitabine as first-line therapy for advanced squamous non-small cell lung cancer (LUME-Lung 3).
Lung Cancer
; 120: 27-33, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29748012
17.
Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA-alkyltransferase: phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumors.
Clin Cancer Res
; 12(5): 1577-84, 2006 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16533784
18.
Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET).
J Clin Oncol
; 35(4): 402-411, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27893326
19.
Erlotinib plus concurrent whole-brain radiation therapy for non-small cell lung cancers patients with multiple brain metastases.
Transl Lung Cancer Res
; 5(2): 208-11, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27186518
20.
Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation Status and Mutation Subtype in Patients with Non-Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
J Thorac Oncol
; 11(3): 312-23, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26749487